What does AF710B do?

Developing therapies for neurodegenerative diseases has proven far more challenging than targeting a single receptor or enzyme. As researchers gained a better understanding of Alzheimer's disease and cognitive disorders, attention gradually shifted toward compounds capable of regulating multiple biological pathways at the same time.

AF710B is one example. Rather than acting on a single target, it combines activity at both the M1 muscarinic acetylcholine receptor and the sigma-1 receptor, two proteins closely associated with neuronal communication and cognitive function.

 

What Is AF710B?

AF710B, also known as ANAVEX 3-71, is a synthetic small molecule developed for neuroscience research. It belongs to a class of compounds that regulate receptor activity through allosteric modulation rather than conventional receptor activation.

One of its defining characteristics is its ability to interact with two different biological targets. At the M1 muscarinic receptor, AF710B functions as an allosteric agonist, influencing receptor activity without competing directly with acetylcholine. At the same time, it activates the sigma-1 receptor, an intracellular protein involved in calcium signaling, mitochondrial regulation, and cellular stress responses.

This combination distinguishes AF710B from many traditional cholinergic compounds. Instead of concentrating on a single signaling pathway, it provides researchers with an opportunity to investigate how multiple neuronal pathways interact during cognitive decline and neurodegeneration.

How Does AF710B Work?

The mechanism of action of AF710B is based on the coordinated regulation of two complementary receptor systems.

The first target is the M1 muscarinic acetylcholine receptor, one of the key receptors involved in learning and memory. Unlike orthosteric agonists that bind directly to the receptor's active site, AF710B interacts with an allosteric binding site. This allows normal cholinergic signaling to be modulated while maintaining receptor selectivity. In experimental studies, this interaction has been associated with intracellular signaling pathways involved in neuronal communication, including ERK and CREB activation.

Its second target, the sigma-1 receptor, serves a very different function. Rather than acting as a classical neurotransmitter receptor, it operates as a molecular chaperone that helps regulate calcium homeostasis, mitochondrial activity, and cellular stress responses. These processes are essential for maintaining normal neuronal function, particularly under conditions associated with aging or neurodegenerative disease.

Instead of working independently, these two receptor systems appear to complement each other. This dual mechanism allows researchers to investigate how cholinergic signaling and intracellular stress regulation influence synaptic function simultaneously, providing a broader understanding of neuronal biology than single-target compounds alone.

 

What Does AF710B Do?

Current knowledge of AF710B comes from cell-based and animal studies, where it has been investigated across several areas of neuroscience research.

A useful tool for cognitive research

The cholinergic system has long been recognized as one of the major pathways involved in learning and memory. Because AF710B selectively modulates the M1 receptor, it is frequently used to examine how changes in cholinergic signaling influence cognitive performance in experimental models.

Rather than simply measuring receptor activation, researchers use AF710B to explore downstream signaling events, neuronal communication, and synaptic function.

Investigated in Alzheimer's disease models

AF710B has also been evaluated in several preclinical models of Alzheimer's disease. Experimental studies have reported changes in pathological markers associated with the disease, including amyloid-beta deposition, tau phosphorylation, synaptic integrity, and neuroinflammatory responses. These findings have encouraged further investigation into how dual-target receptor modulation may influence multiple aspects of neurodegenerative pathology.

Supports receptor pharmacology research

Beyond Alzheimer's disease, AF710B has become a useful compound for investigating receptor biology. Its pharmacological profile allows researchers to evaluate M1 receptor selectivity, sigma-1 receptor signaling, intracellular communication, and GPCR-related pathways within a single experimental system.

 

Why To Buy?

AF710B is a dual-target research chemical developed for studies of neuronal signaling and cognitive function. If you plan to buy AF710B raw material powder, then the following characteristics are things you should be aware of:

1. Good formulation compatibility: AF710B powder shows strong compatibility in formulation systems and is commonly used in multi-component blend development and compatibility testing.

2. Good stability: As a solid raw material, AF710B powder maintains relatively stable physical properties under standard storage and transportation conditions, making it suitable for long-term inventory management and batch usage.

3. Solvent adaptability and dispersibility: It demonstrates certain dispersibility across different solvent systems and is often used in early-stage solubility observation and basic formulation compatibility evaluation, helping to screen suitable processing routes.

4. High purity: AF710B powder is typically supplied with high purity specifications, making it suitable for laboratory development and small-scale formulation systems that require consistent raw material quality. It helps reduce interference from impurities and improves batch-to-batch reproducibility.

 

Product name	High Purity AF710B Powder
CAS No.	1235733-73-9
MF	C20H27N3OS
MW	357.51
Boiling point	591.0±50.0 °C(Predicted)
Density	1.24±0.1 g/cm3(Predicted)
Storage	Keep in dark place,Inert atmosphere,Room temperature
Shelf Life	2 Years

 Jinan Jianfeng Chemical Co., Ltd. is a China-based chemical manufacturer established in 2001 and located in Jinan, Shandong Province. Our company focuses on the production and supply of pharmaceutical intermediates, APIs, and fine chemicals for global markets. If you have any requirements, please contact us. We will offer you the most suitable solution. sales01@pharmachemm.com

 

 

Disclaimer:

The information on this website is for communication and learning purposes only and is not medical advice. It should not be used for diagnosing or treating any illness.